June 5, 2019
Tag: Prostate Cancer
June 4, 2019
EverydayHealth: Access to Quality Health Insurance Improves Cancer Screening, Survival, and More From the Annual Meeting of the American Society of Clinical Oncology
June 2, 2019
Associated Press: Drugs make headway against lung, breast, prostate cancers
June 2, 2019
HemOnc Today: Men choosing active prostate cancer surveillance show low rates of follow-up monitoring
June 2, 2019
Men with early-stage prostate cancer who choose active surveillance often don’t follow monitoring guidelines
Preliminary results from a University of North Carolina Lineberger Comprehensive Cancer Center study found that just 15 percent of a group of men in North Carolina with early-stage prostate cancer who choose active surveillance instead of treatment followed the recommended monitoring guidelines. The findings, which were presented today at the American Society of Clinical Oncology …
January 7, 2019
Healthcare Finance: How employers can improve cancer care and costs, based on a National Alliance roadmap
September 13, 2018
Prostate cancer care for older men estimated to cost Medicare $1.2B
Researchers led by UNC Lineberger's Ronald C. Chen, MD, MPH, and Justin Trogdon, PhD, examined the costs associated with screening for prostate cancer, including treatment, for three years after diagnosis. They estimated that for men diagnosed in each of 2004, 2005, 2006, and 2007, the total cost for treating and screening for each group would be $1.2 billion for three years after diagnosis.
June 2, 2018
More frequent screening after prostate cancer treatment not linked to improved survival
At the 2018 American Society of Clinical Oncology Annual Meeting, UNC Lineberger's Ronald Chen, MD, MPH, and colleagues presented findings from a study that assessed whether monitoring prostate cancer patients following treatment with a PSA test every three months versus once a year would provide a long-term survival benefit.
February 19, 2018
American Society of Clinical Oncology’s annual report features UNC Lineberger research
Research findings by Ethan Basch, MD, MSc, and Ronald C. Chen, MD, MPH, were cited as being among the most impactful advances and policy developments in cancer in 2017.
February 17, 2016
Low-risk prostate cancer best managed with active surveillance
UNC Lineberger researcher Dr. Ronald C. Chen was first-author of a report published in the Journal of Clinical Oncology that details guidelines for the active surveillance of men with low-risk prostate cancer. The guidelines, originally authored by Cancer Care Ontario, were reviewed and endorsed by the American Society of Clinical Oncology.